159 related articles for article (PubMed ID: 1495828)
1. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Reynaud AE; Espaze EP; Coste-Burel M; Richet H
Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
[TBL] [Abstract][Full Text] [Related]
3. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
[TBL] [Abstract][Full Text] [Related]
4. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
David C; Chaste A; Saison C; Combremont AG
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of fusidic acid in combination with various antibiotics against Staphylococcus epidermidis].
Fosse T; Appert A; Delpech D; Laffont C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):621-5. PubMed ID: 3054737
[TBL] [Abstract][Full Text] [Related]
6. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Norazah A; Lim VK; Rohani MY; Kamel AG
Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
[TBL] [Abstract][Full Text] [Related]
10. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
13. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
[TBL] [Abstract][Full Text] [Related]
15. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Harvey K; Pavillard R
Med J Aust; 1982 May; 1(11):465-7. PubMed ID: 7048040
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model.
Lister PD
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S33-8. PubMed ID: 11249827
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
18. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
19. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
20. [Activity of ofloxacin and other fluoroquinolones against staphylococcus which is either resistant to or susceptible to methicillin].
Gospodarek E; Wojak I
Med Dosw Mikrobiol; 1994; 46(4):237-46. PubMed ID: 7603125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]